BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 224 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,168,000 | +26.8% | 17,737 | -2.7% | 0.00% | +100.0% |
| Q2 2022 | $921,000 | -27.5% | 18,233 | -8.3% | 0.00% | -50.0% |
| Q1 2022 | $1,270,000 | -41.0% | 19,890 | -1.0% | 0.00% | -33.3% |
| Q4 2021 | $2,151,000 | +1.4% | 20,088 | -2.7% | 0.00% | 0.0% |
| Q3 2021 | $2,122,000 | +634.3% | 20,639 | +527.1% | 0.00% | – |
| Q2 2021 | $289,000 | +21.4% | 3,291 | +34.3% | 0.00% | – |
| Q1 2021 | $238,000 | -13.8% | 2,450 | -0.5% | 0.00% | – |
| Q4 2020 | $276,000 | -8.3% | 2,462 | -24.2% | 0.00% | -100.0% |
| Q3 2020 | $301,000 | +2.7% | 3,250 | -13.4% | 0.00% | 0.0% |
| Q2 2020 | $293,000 | +6.5% | 3,751 | +9.5% | 0.00% | 0.0% |
| Q4 2019 | $275,000 | -72.0% | 3,425 | -67.1% | 0.00% | -66.7% |
| Q2 2019 | $983,000 | – | 10,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |